|
2020 Journal Article Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patientsYadav, Rajbharan, Bergen, Phillip J., Rogers, Kate E., Kirkpatrick, Carl M. J., Wallis, Steven C., Huang, Yuling, Bulitta, Jürgen B., Paterson, David L., Lipman, Jeffrey, Nation, Roger L., Roberts, Jason A. and Landersdorfer, Cornelia B. (2020). Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients. Antimicrobial Agents and Chemotherapy, 64 (1) e01679-19. doi: 10.1128/aac.01679-19 |
|
2020 Journal Article Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populationsXie, Jiao, Roberts, Jason A., Lipman, Jeffrey, Cai, Yan, Wang, Haitao, Zhao, Nuannuan, Xu, Xiaona, Yang, Shan, Li, Youjia and Zhang, Kanghuai (2020). Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations. International Journal of Antimicrobial Agents, 55 (6) 105943, 105943. doi: 10.1016/j.ijantimicag.2020.105943 |
|
2019 Journal Article Antimicrobial resistance: we must pursue a collaborative, global approach and use a “one health” approachLonsdale, Dagan O. and Lipman, Jeffrey (2019). Antimicrobial resistance: we must pursue a collaborative, global approach and use a “one health” approach. Antibiotics, 8 (4) 237, 237. doi: 10.3390/antibiotics8040237 |
|
2019 Journal Article Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN)Ranganathan, Dwarakanathan, Abdul-Aziz, Mohd H., John, George T., McWhinney, Brett C., Fassett, Robert G., Healy, Helen, Kubler, Paul, Lim, Aaron, Lipman, Jeffrey, Purvey, Megan, Roberts, Matthew, Reyaldeen, Reza, Ungerer, Jacobus and Roberts, Jason A. (2019). Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN). Therapeutic Drug Monitoring, 41 (6), 703-713. doi: 10.1097/ftd.0000000000000658 |
|
2019 Journal Article Survey of critical care practice in Australian and New Zealand burn referral centresHolley, Anthony D., Reade, Michael C., Lipman, Jeffrey, Delaney, Anthony, Udy, Andrew, Lee, Richard, Litton, Edward, Cheung, Winston, Turner, Andrew, Garside, Tessa, Macken, Lewis, Reddi, Benjamin, Kol, Mark, Kazemi, Alex, Shah, Asim, Townsend, Shane and Cohen, Jeremy (2019). Survey of critical care practice in Australian and New Zealand burn referral centres. Critical Care and Resuscitation, 21 (4), 303-304. |
|
2019 Journal Article Saturable elimination of piperacillin in critically ill patients: implications for continuous infusionDhaese, S.A.M., Colin, P., Willems, H., Heffernan, A., Gadeyne, B., Van Vooren, S., Depuydt, P., Hoste, E., Stove, V., Verstraete, A.G., Lipman, J., Roberts, J.A. and De Waele, J.J. (2019). Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion. International Journal of Antimicrobial Agents, 54 (6), 741-749. doi: 10.1016/j.ijantimicag.2019.08.024 |
|
2019 Journal Article A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic studyParker, Suzanne L., Pandey, Saurabh, Sime, Fekade B., Lipman, Jeffrey, Roberts, Jason A. and Wallis, Steven C. (2019). A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic study. Analytical and Bioanalytical Chemistry, 411 (29), 7831-7840. doi: 10.1007/s00216-019-02184-4 |
|
2019 Journal Article Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future hospital-acquired/ventilator-associated bacterial pneumonia clinical trialsWeiss, Emmanuel, Zahar, Jean-Ralph, Alder, Jeff, Asehnoune, Karim, Bassetti, Matteo, Bonten, Marc J. M, Chastre, Jean, De Waele, Jan, Dimopoulos, George, Eggimann, Philippe, Engelhardt, Marc, Ewig, Santiago, Kollef, Marin, Lipman, Jeffrey, Luna, Carlos, Martin-Loeches, Ignacio, Pagani, Leonardo, Palmer, Lucy B, Papazian, Laurent, Poulakou, Garyphallia, Prokocimer, Philippe, Rello, Jordi, Rex, John H, Shorr, Andrew F, Talbot, George H, Thamlikitkul, Visanu, Torres, Antoni, Wunderink, Richard G and Timsit, Jean-François (2019). Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future hospital-acquired/ventilator-associated bacterial pneumonia clinical trials. Clinical Infectious Diseases, 69 (11), 1912-1918. doi: 10.1093/cid/ciz093 |
|
2019 Journal Article Development and validation of LC-MS/MS methods to measure tobramycin and lincomycin in plasma, microdialysis fluid and urine: application to a pilot pharmacokinetic research studyPandey, Saurabh, Dhanani, Jayesh, Lipman, Jeffrey, Roberts, Jason A., Wallis, Steve C. and Parker, Suzanne L. (2019). Development and validation of LC-MS/MS methods to measure tobramycin and lincomycin in plasma, microdialysis fluid and urine: application to a pilot pharmacokinetic research study. Clinical Chemistry and Laboratory Medicine, 58 (2), 274-284. doi: 10.1515/cclm-2019-0780 |
|
2019 Journal Article Pharmacokinetics of total and unbound cefazolin during veno-arterial extracorporeal membrane oxygenation: a case reportDhanani, Jayesh A., Lipman, Jeffrey, Pincus, Jason, Townsend, Shane, Livermore, Amelia, Wallis, Steven C., Abdul-Aziz, Mohd H. and Roberts, Jason A. (2019). Pharmacokinetics of total and unbound cefazolin during veno-arterial extracorporeal membrane oxygenation: a case report. Chemotherapy, 64 (3), 1-4. doi: 10.1159/000502474 |
|
2019 Journal Article A Multicenter Trial of Vena Cava Filters in Severely Injured Patients. ReplyHo, Kwok M., Rogers, Frederick B. and Lipman, Jeffrey (2019). A Multicenter Trial of Vena Cava Filters in Severely Injured Patients. Reply. The New England journal of medicine, 381 (15), 1496-1497. doi: 10.1056/NEJMc1911302 |
|
2019 Journal Article The authors reply to: A multicenter trial of vena cava filters in severely injured patientsHo, Kwok M., Rogers, Frederick B. and Lipman, Jeffrey (2019). The authors reply to: A multicenter trial of vena cava filters in severely injured patients. The New England Journal of Medicine, 381 (15), 1496-1497. doi: 10.1056/NEJMc1911302 |
|
2019 Journal Article Lefamulin. Comment on: “Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms, 2019, 7, 270”Koulenti, Despoina, Xu, Elena, Yin Sum Mok, Isaac, Song, Andrew, Karageorgopoulos, Drosos E., Armaganidis, Apostolos, Lipman, Jeffrey and Tsiodras, Sotirios (2019). Lefamulin. Comment on: “Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms, 2019, 7, 270”. Microorganisms, 7 (10) 386, 386. doi: 10.3390/microorganisms7100386 |
|
2019 Journal Article A review of -multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg, South AfricaBallot, Daynia E., Bandini, Rosella, Nana, Trusha, Bosman, Noma, Thomas, Teena, Davies, Victor A., Cooper, Peter A., Mer, Mervyn and Lipman, Jeffrey (2019). A review of -multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg, South Africa. BMC Pediatrics, 19 (1) 320, 320. doi: 10.1186/s12887-019-1709-y |
|
2019 Journal Article Does intermittent pneumatic compression PREVENT deep vein thrombosis in the ICU?Laupland, Kevin B., Tabah, Alexis, Kelway, Charlotte and Lipman, Jeffrey (2019). Does intermittent pneumatic compression PREVENT deep vein thrombosis in the ICU?. Anaesthesia Critical Care and Pain Medicine, 38 (4), 303-304. doi: 10.1016/j.accpm.2019.05.006 |
|
2019 Journal Article Novel antibiotics for multidrug-resistant gram-positive microorganismsKoulenti, Despoina, Xu, Elena, Mok, Isaac Yin Sum, Song, Andrew, Karageorgopoulos, Drosos E., Armaganidis, Apostolos, Lipman, Jeffrey and Tsiodras, Sotirios (2019). Novel antibiotics for multidrug-resistant gram-positive microorganisms. Microorganisms, 7 (8), 270. doi: 10.3390/microorganisms7080270 |
|
2019 Journal Article In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltrationT.P. Wan, Winnie, Guerra Valero, Yarmarly, Choi, Gordon Y.S., Ordóñez Mejia, Jenny L., Wallis, Steven C., Joynt, Gavin M., Lipman, Jeffrey, Gomersall, Charles D. and Roberts, Jason A. (2019). In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration. International Journal of Antimicrobial Agents, 54 (2), 261-264. doi: 10.1016/j.ijantimicag.2019.03.018 |
|
2019 Journal Article Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: a prospective observational studyDhaese, Sofie A.M., Thooft, Alexander D.J., Farkas, Andras, Lipman, Jeffrey, Verstraete, Alain G., Stove, Veronique, Roberts, Jason A. and De Waele, Jan J. (2019). Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: a prospective observational study. Journal of Critical Care, 52, 75-79. doi: 10.1016/j.jcrc.2019.04.013 |
|
2019 Journal Article Vena Cava filters in severely-injured patients: one size does not fit allHo, Kwok M., Holley, Anthony and Lipman, Jeffrey (2019). Vena Cava filters in severely-injured patients: one size does not fit all. Anaesthesia Critical Care and Pain Medicine, 38 (4), 305-307. doi: 10.1016/j.accpm.2019.07.003 |
|
2019 Journal Article Population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal dysfunctionSime, Fekade B., Lassig-Smith, Melissa, Starr, Therese, Stuart, Janine, Pandey, Saurabh, Parker, Suzanne L., Wallis, Steven C., Lipman, Jeffrey and Roberts, Jason A. (2019). Population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal dysfunction. Antimicrobial Agents and Chemotherapy, 63 (10) e01265-19. doi: 10.1128/aac.01265-19 |
